EUVIMEDEUVIMED entdecken
Crossref

The effect of lymphocyte immunotherapy (LIT) in modulating immune responses in patients with recurrent pregnancy loss (RPL)

Lida Aslanian-Kalkhoran, Amin Kamrani, Iraj Alipourfard, Forough Chakari-Khiavi, Aref Chakari-Khiavi, Leili Aghebati-Maleki, Ali Akbar Shekarchi, Amir Mehdizadeh, Maryam Mojahedi, Shahla Danaii, Leila Roshangar, Javad Ahmadian Heris und 4 weitere

International Immunopharmacology · 2023-08 · 121 · 110326

DOI: 10.1016/j.intimp.2023.110326 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2023-08. Verfasst von Lida Aslanian-Kalkhoran und 15 weiteren Autor:innen. Beteiligte Einrichtung: Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Immunology, School of Medicine, Tabriz University of M…. Hauptthemen laut MEDLINE: MicroRNAs, Abortion, Habitual. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 79 Literaturangaben. Gefördert von: Tabriz University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In order to prevent miscarriage in RPL patients, the goal of this study was to determine how well lymphocyte immunotherapy (LIT) works in modifying immunological responses produced by cells, cytokines, transcription factors, and microRNAs. 200 RPL patients and 200 healthy controls were included in the study. Using flow cytometry, it was possible to compare the frequency of cells before and after lymphocyte treatment. Real-time PCR was used to assess the gene expression levels of transcription factors, cytokines, and microRNAs. ELISA method was used to evaluate the level of secretion of cytokines in the serum. Primary evaluation of the immune profile between healthy controls and RPL cases showed a higher frequency of Th17, NK, B cells and a lower frequency of Treg cells in RPL cases. Also, pro-inflammatory cytokines showed increased expression at mRNA and protein levels in the RPL group in comparison with the control group. Whereas, anti-inflammatory cytokines showed decreased expression in RPL patients. Decreased and increased frequency of Th17 and Treg lymphocytes observed in RPL cases following LIT, respectively. The same results obtained for RORγt and FoxP3 mRNA expression as transcription factor of Th17 and Treg cells, respectively. NK cell cytotoxicity decreased after LIT in RPL patients. miR-326a and miR-155 expression after LIT reduced, but miR-146a and miR-10a expression increased in RPL instances. LIT in RPL cases causes to elevation and modulation of anti-inflammatory and pro-inflammatory cytokines. Our data showed that lymphocyte therapy can be proposed as an effective therapeutic agent in RPL patients with immunological background by a modulating inflammatory condition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsAbortion, HabitualPregnancyFemaleHumansLymphocytesImmunotherapyCytokinesTranscription FactorsImmunityRNA, MessengerAnti-Inflammatory Agents

Stichwörter der Autor:innen

Immunological disordersLITLymphocyte immunotherapyRecurrent miscarriageRecurrent pregnancy loss

Substanzen

MicroRNAsCytokinesTranscription FactorsRNA, MessengerAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Immunology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Institute of Physical Chemistry, Polish Academy of Sciences, Warsaw, Poland.
  • Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Student Research Committee, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran.
  • Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Department of Pathology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.

Förderung

  • Tabriz University of Medical Sciences

Zitieren

APA

Aslanian-Kalkhoran, L., Kamrani, A., Alipourfard, I., Chakari-Khiavi, F., Chakari-Khiavi, A., Aghebati-Maleki, L., Shekarchi, A. A., Mehdizadeh, A., Mojahedi, M., Danaii, S., Roshangar, L., Ahmadian Heris, J., Zolfaghari, M., Dolati, S., Soltani-Zangbar, M. S., & Yousefi, M. (2023). The effect of lymphocyte immunotherapy (LIT) in modulating immune responses in patients with recurrent pregnancy loss (RPL). International Immunopharmacology, 121, 110326. https://doi.org/10.1016/j.intimp.2023.110326

Vancouver

Aslanian-Kalkhoran L, Kamrani A, Alipourfard I, Chakari-Khiavi F, Chakari-Khiavi A, Aghebati-Maleki L, et al. The effect of lymphocyte immunotherapy (LIT) in modulating immune responses in patients with recurrent pregnancy loss (RPL). International Immunopharmacology. 2023;121:110326. doi:10.1016/j.intimp.2023.110326

BibTeX
@article{AslanianKalkhoran2023,
  author = {Aslanian-Kalkhoran, Lida and Kamrani, Amin and Alipourfard, Iraj and Chakari-Khiavi, Forough and Chakari-Khiavi, Aref and Aghebati-Maleki, Leili and Shekarchi, Ali Akbar and Mehdizadeh, Amir and Mojahedi, Maryam and Danaii, Shahla and Roshangar, Leila and Ahmadian Heris, Javad and Zolfaghari, Mohammadali and Dolati, Sanam and Soltani-Zangbar, Mohammad Sadegh and Yousefi, Mehdi},
  title = {The effect of lymphocyte immunotherapy (LIT) in modulating immune responses in patients with recurrent pregnancy loss (RPL)},
  journal = {International Immunopharmacology},
  year = {2023},
  volume = {121},
  pages = {110326},
  doi = {10.1016/j.intimp.2023.110326}
}
Kostenlos starten →